期刊文献+

华氏巨球蛋白血症的骨髓病理特点与鉴别 被引量:1

Bone marrow pathologic features and differentiation of Waldenstr(o)m macroglobulinemia
原文传递
导出
摘要 目的 探讨华氏巨球蛋白血症(WM)的骨髓病理特点、诊断与鉴别.方法 19例WM患者行骨髓穿刺(BMA)及骨髓活组织检查(BMB)进行形态学观察,用流式细胞术(FCM)及免疫组织化学(IHC)方法 进行免疫表犁分析.结果 11例BMA示浆细胞样淋巴细胞增生.BMB示19例均见瘤细胞侵犯,其中17例主要为小淋巴细胞增生,2例主要为浆细胞样淋巴细胞增生.4例未见典型的浆细胞样淋巴细胞.骨髓侵犯呈弥漫型12例,结节型4例,间质型3例.FCM示14例瘤细胞CD19^+、CD20^+、CD22^+、CD5^-、CD10^-.IHC示小淋巴细胞及浆细胞样淋巴细胞CD20^+、Pax5^+,浆细胞CD38^+、CD138^+、CD20^-、Pax5^-.结论 小淋巴细胞增生伴有浆细胞样分化是WM的典型骨髓病理组织学改变,IHC有利于识别淋巴细胞及浆细胞两种不同的细胞成分.形态学与FCM、IHC相结合有助于WM的诊断与鉴别. Objective To explore the bone marrow pathology ,diagnosis and differential diagnosis of Waldenstrom macroglobulinemia(WM). Methods 19 WM patients was examined by bone marrow aspiration (BMA) and bone marrow biopsy (BMB) for morphology. Flow cytometry (FCM) and immunohistochemistry (IHC) for immunophenotyping. Results Plasmacytoid lymphocytes were identified in 11 BMA. All of 19 BMB were involved by lymphoma cells. 17 cases showed a predominance of small lymphocytes and 2 of plasmacytoid lymphocytes. Typically plasmacytoid lymphocytes were not seen in 4 cases. Patterns of bone marrow involvement were as follow: diffuse (12 cases), nodular (4 cases), interstitial (3 cases). Immunophenotypically, FCM showed all cases were CD19^+、CD20^+、CD22^+、CD5^-、CD10^-. IHC revealed small lymphocytes and plasmacytoid lymphocytes were Pax5^+ CD20^+ and plasma cells were CD38 CD138^+ CD20^- Pax5^-. Conclusion Small lymphocytes proliferation with plasmacytic differentiation is the typical bone marrow pathologic features of WM. IHC is benefit for identifying lymphocytes and plasma cells components. The Combination of morphology, FCM and IHC is contributive to the diagnosis and differentiation of WM.
出处 《白血病.淋巴瘤》 CAS 2010年第5期281-283,286,共4页 Journal of Leukemia & Lymphoma
关键词 Waldenstr(o)m巨球蛋白血症 骨髓检查 病理学 临床 免疫表型分型 诊断 Waldenstroem macroglobulinemia Bone marrow examination Pathology, clinical Immunophenotyping Diagnosis
  • 相关文献

参考文献11

  • 1Owen RG,Treon SP,Alkatib A,et al.Clinicopathological definition of waldenstrSm macroglobulinemia:consensus panel recommendations from the second international workshop on Waldenstrom marroglobulinemia.Semi Oncol,2003,30:110-115.
  • 2Swerdlow SH,Berger F,Pileri SA,et al.Lymphoplasmacytic lymphoma// Swerdlow SH,Campo E,Harris NL,et al.WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues.4th ed.Lyon:IARC Press,2008:194-195.
  • 3Viswanatha D,Foucar K.Hodgkin and non-Hodgkin lymphoma involving bone marrow.Semi Diagn Pathol,2003,20:196-210.
  • 4Vijay A.Gertz MA.Waldenstr(o)m macroglobulinemia.Blooa,2007,109:5096-5103.
  • 5陈心传,勾红峰,徐才刚.华氏巨球蛋白血症22例临床分析[J].四川医学,2007,28(2):161-163. 被引量:3
  • 6王晓燕,季林祥,杨仁池.Waldenstrom巨球蛋白血症24例临床分析[J].白血病.淋巴瘤,2007,16(1):30-32. 被引量:4
  • 7王莉,徐卫,仇红霞,李建勇.原发性巨球蛋白血症15例[J].白血病.淋巴瘤,2008,17(6):433-435. 被引量:4
  • 8Lin P,Medeiros LJ.Lymphoplasmacytic lymphoma/Waldenstr(o)m macroglobulinemia-an evolving concept.Adv Anat Pathol,2005,12:246-255.
  • 9Berger F,Isaacson PC,Piris MA,et al.Lymphoplasmacytic lymphoma/waldenstr(o)m macroglobulinemia// Jaffe ES,Harris NL,Stein,et al.World Health Organization Classification of Tumors-Pathology and Genetics of Tumors of Haematopoietic and Lymphoid Tissues.3th ed.Lyon:IARC Press,2001.
  • 10Morice WG,Chen D,Kurtin PJ,et al.Novel immunophenotypic features of marrow lymphoplasmacytic lymphoma and correlation with waldenstr?m macroglobulinemia.Mod Pathol,2009,22:807-816.

二级参考文献35

  • 1王晓燕,杨仁池.华氏巨球蛋白血症的治疗进展[J].国际输血及血液学杂志,2006,29(2):154-157. 被引量:3
  • 2Gertz MA, Fonseca R, Rajkumar SV. Waldenstrom's macroglobulinemia[J]. Oncologist, 2000, 5(1): 63-67.
  • 3Garcia-Sanz R, Montoto S, Torrequebrada A, et al, Waldenstrom macroglobulinaemia: presenting features and outcome in a series with 217 cases[J]. Br J Haematol, 2001, 115(3): 575-582.
  • 4Owen RG, Treon SP, Al-Katib A, et al .Clinicopathological definition of Waldenstrom's maeroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Maeroglobulinemia[J]. Semin Oneol, 2003, 30(2): 110-115.
  • 5Owen RG, Barrans SL, Richards SJ, et al. Waldenstrom macroglobulinemia. Development of diagnostic criteria and identification of prognostic factors[J]. Am J Clin Pathol, 2001, 116 (3): 420-428.
  • 6Konoplev S, Medeiros LJ, Bueso-Ramos CE, et al. Immunophenotypic profile of lymphoplasmacytic lymphoma/ Waldenstrom macroglobulinemia[J]. Am J Clin Pathol, 2005, 124 (3): 414-420.
  • 7Ocio EM, Schop RF, Gonzalez B, et al. 6q deletion in Waldenstrom macroglobulinemia is associated with features of adverse prognosis [J]. Br J Haematol, 2007, 136(1): 80-86.
  • 8Anagnostopoulos A, Zervas K, Kyrtsonis M, et al. Prognostic value of serum beta2-microglobulin in patients with Waldenstrom's macroglobulinemia requiring treatment [J]. Clin Lymphoma Myeloma, 2006, 7(3): 205-209.
  • 9Ghobrial IM, Fonseca R, Gertz MA, et al. Prognostic model for disease -specific and overall mortality in newly diagnosed symptomatic patients with Waldenstrom maeroglobulinaemia[J]. Br J Haematol, 2006, 133(2): 158-164.
  • 10Tamburini J, Levy V, Chaleteix C, et al. Fludarabine plus eyclophosphamide in Waldenstrom's macroglobulinemia: results in 49 patients[J]. Leukemia, 2005, 19(10): 1831-1834.

共引文献5

同被引文献10

  • 1Berentsen S,Ulvestad E,Langholm R,吴敏(节译),陈会友(审校),田兆嵩(审校).86例原发性慢性冷凝集素疾病病人临床研究[J].国际输血及血液学杂志,2007,30(5):477-478. 被引量:3
  • 2Swerdlow SH,Campo E,Harris NL,et al.(2008) WHO classification of tumors hematopoietic and lymphoid tissues[M].Lyon:IARC Press,2008:194-195.
  • 3Ghobrial IM,Fonseca R,Gertz MA,et al.Prognostic model for disease-specific and overall mortality in newly diagnosed symptomatic patients with Waldenstrom macroglobulinaemia[J].Br J Haematol,2006,133:158-164.
  • 4Owen RG,Treon SP,AL-katib A,et al.Clinicopathological definition of Waldenstrom's macroglobulinemia:consensus panel recommendations from the Sencond International Workshop on Waldenstrom's Macroglobulinemia[J].Semin Oncol,2003,30:110-115.
  • 5Treon SP,Hunler ZR,Aggarwai A,et al.Characlerization of familial Waldenstrom's macroglobulinemian[J].Ann Oncol,2006,17:488-496.
  • 6Berentsen S.Cold agglutinin mediated autoimmune hemolytic anemia in Waldenstroms's macroglobulinemia[J].Clin Lymphoma Myeloma,2009,9:110-112.
  • 7Gertz MA.Coldhemolytic syndrome[M].Am Soc Hematol Education Program Book,2006:19-23.
  • 8Treon SP,Gertz MA,Dimopoulos M,et al.Update on treatment recommendations from the Third International Workshop on Waldenstroms' macroglobulinemia[J].Blood,2006,107:3442-3446.
  • 9周可树,邱录贵.淋巴浆细胞淋巴瘤/Waldenstri?m巨球蛋白血症的诊断及治疗[J].中华血液学杂志,2010,31(4):285-287. 被引量:3
  • 10陈滨海,沈一平,叶宝东,周郁鸿,沈建平.冷凝集素综合征并发双下肢静脉血栓形成一例并文献复习[J].中国医药,2010,5(7):678-679. 被引量:4

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部